Biodexa Pharmaceuticals Plc
BDRX
$1.55
-$0.01-0.64%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -72.53% | -69.30% | -3.82% | -1.27% | 122.57% |
Total Receivables | -0.18% | 11.55% | 20.54% | 23.74% | -49.58% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 1,679.06% | 1,888.18% | -- | -- | -0.18% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 23.17% | 37.64% | 3.01% | 5.74% | 58.53% |
|
|||||
Total Current Assets | 23.17% | 37.64% | 3.01% | 5.74% | 58.53% |
Net Property, Plant & Equipment | -44.23% | -37.67% | -37.44% | -35.76% | -27.36% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 88.69% | 110.86% | 118,539.06% | 122,287.10% | 51,929.17% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 37.80% | 53.99% | 74.47% | 79.10% | 101.71% |
|
|||||
Total Accounts Payable | 121.28% | 147.29% | -4.29% | -1.75% | -2.08% |
Total Accrued Expenses | 46.00% | 63.15% | -- | -- | 10.89% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 4.09% | 16.34% | 5.52% | 8.33% | 10.98% |
Total Finance Division Other Current Liabilities | -43.17% | -36.50% | 342.02% | 353.81% | 666.79% |
Total Other Current Liabilities | -43.17% | -36.50% | 342.02% | 353.81% | 666.79% |
Total Current Liabilities | -11.16% | -0.72% | 51.64% | 55.66% | 209.85% |
|
|||||
Total Current Liabilities | -11.16% | -0.72% | 51.64% | 55.66% | 209.85% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -60.70% | -56.06% | -45.56% | -44.12% | -32.64% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 8.24% | 20.96% | 95.72% | 100.92% | 162.34% |
|
|||||
Common Stock & APIC | 4.48% | 16.75% | 11.08% | 14.03% | 10.95% |
Retained Earnings | -2.13% | -14.12% | -5.82% | -8.63% | -13.08% |
Treasury Stock & Other | 4.30% | 16.55% | 3.47% | 6.22% | 18.85% |
Total Common Equity | 74.85% | 95.39% | 63.78% | 68.13% | 56.40% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 74.85% | 95.39% | 63.78% | 68.13% | 56.40% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 74.85% | 95.39% | 63.78% | 68.13% | 56.40% |
|